Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
- PMID: 20444258
- PMCID: PMC2882354
- DOI: 10.1186/1477-9560-8-7
Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
Abstract
Background: Tissue factor (TF) and its inhibitor tissue factor pathway inhibitor (TFPI) are the main regulators of the initiation of the coagulation process, important in atherothrombosis. In this study we have investigated the frequency of six known TF and TFPI single nucleotide polymorphisms (SNPs) in CHD patients as compared to healthy individuals. These genotypes and the phenotypes (TF, TFPI free and total antigen) were evaluated with special reference to gender and diabetes in the CHD population.
Methods: Patients with angiographically verified CHD (n = 1001; 22% women, 20% diabetics), and 204 healthy controls (28% women), were included. The investigated SNPs were: TF -1812C/T and TF -603A/G in the 5'upstream region, TF 5466A/G in intron 2, TFPI -399C/T and TFPI -287T/C in the 5'upstream region and the TFPI -33T/C in intron 7.
Results: No significant differences in frequencies between the CHD population and the controls of any polymorphisms were observed. In the CHD population, the TF 5466 A/G SNP were significantly more frequent in women as compared to men (p < 0.001). The TF-1812C/T and the TF-603A/G SNPs were significantly more frequent in women without type-2 diabetes compared to those with diabetes (p < 0.018, both), and the heterozygous genotypes were associated with significantly lower TF plasma levels compared to the homozygous genotypes (p < 0.02, both).The TFPI-399C/T and the TFPI-33T/C SNPs were associated with lower and higher TFPI total antigen levels, respectively (p < 0.001, both).
Conclusion: Genetic variations in the TF and TFPI genes seem to be associated with gender and type-2 diabetes, partly affecting their respective phenotypes.
Figures
Similar articles
-
[Association of single nucleotide polymorphisms of tissue factor and tissue factor pathway inhibitor with venous thromboembolism in patients with lung cancer].Zhonghua Yi Xue Za Zhi. 2018 Mar 27;98(12):901-906. doi: 10.3760/cma.j.issn.0376-2491.2018.12.005. Zhonghua Yi Xue Za Zhi. 2018. PMID: 29665662 Chinese.
-
Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.Blood Coagul Fibrinolysis. 2010 Sep;21(6):516-21. doi: 10.1097/MBC.0b013e32833a06cd. Blood Coagul Fibrinolysis. 2010. PMID: 20453636
-
Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathway inhibitor in venous thromboembolism.Blood Coagul Fibrinolysis. 2014 Jul;25(5):416-21. doi: 10.1097/MBC.0000000000000063. Blood Coagul Fibrinolysis. 2014. PMID: 24448154
-
Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.Eur J Obstet Gynecol Reprod Biol. 2011 Sep;158(1):37-41. doi: 10.1016/j.ejogrb.2011.04.026. Epub 2011 Jun 12. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21664032 Review.
-
Structure and biology of tissue factor pathway inhibitor.Thromb Haemost. 2001 Oct;86(4):959-72. Thromb Haemost. 2001. PMID: 11686353 Review.
Cited by
-
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis.Thromb Haemost. 2023 Aug;123(8):808-839. doi: 10.1055/a-2052-9175. Epub 2023 Mar 13. Thromb Haemost. 2023. PMID: 36913975 Free PMC article.
-
Tissue factor levels in type 2 diabetes mellitus.Inflamm Res. 2017 May;66(5):365-368. doi: 10.1007/s00011-017-1030-x. Epub 2017 Feb 28. Inflamm Res. 2017. PMID: 28246677
-
Low-grade risk of hypercoagulable state in patients suffering from diabetes mellitus type 2.J Zhejiang Univ Sci B. 2015 Sep;16(9):788-95. doi: 10.1631/jzus.B1500066. J Zhejiang Univ Sci B. 2015. PMID: 26365121 Free PMC article.
-
Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease.Mol Genet Genomics. 2018 Feb;293(1):119-128. doi: 10.1007/s00438-017-1365-6. Epub 2017 Sep 11. Mol Genet Genomics. 2018. PMID: 28894953 Free PMC article.
-
Influence of tissue factor polymorphisms (603A>G and 5466A>G) on plasma tissue factor levels and their impact on deep vein thrombosis risk in young Indian population.J Thromb Thrombolysis. 2018 Jul;46(1):88-94. doi: 10.1007/s11239-018-1666-6. J Thromb Thrombolysis. 2018. PMID: 29789989
References
-
- Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost. 2001;86:959–972. - PubMed
-
- Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG, Bajaj SP. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA. 1990;87:8869–8873. doi: 10.1073/pnas.87.22.8869. - DOI - PMC - PubMed
-
- Broze GJ Jr. Tissue factor pathway inhibitor. Thromb Haemost. 1995;74:90–93. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous